104 related articles for article (PubMed ID: 31345366)
1. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
[TBL] [Abstract][Full Text] [Related]
2. Copper to Zinc Ratio as Disease Biomarker in Neonates with Early-Onset Congenital Infections.
Wisniewska M; Cremer M; Wiehe L; Becker NP; Rijntjes E; Martitz J; Renko K; Bührer C; Schomburg L
Nutrients; 2017 Mar; 9(4):. PubMed ID: 28358335
[TBL] [Abstract][Full Text] [Related]
3. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.
Guo CH; Wang CL
Int J Med Sci; 2013; 10(1):79-89. PubMed ID: 23289009
[TBL] [Abstract][Full Text] [Related]
4. Effects of Acetylcholinesterase Inhibitors on Balance and Gait Functions and Orthostatic Hypotension in Elderly Patients With Alzheimer Disease.
Isik AT; Soysal P; Usarel C
Am J Alzheimers Dis Other Demen; 2016 Nov; 31(7):580-584. PubMed ID: 27585748
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of Plasma Copper and Zinc Levels and the Association Between the Cu/Zn Ratio and Lipid Peroxidation in Algerian Bipolar Patients.
Chebieb I; Medjati ND; Harek Y; Guermouche B; Dali-Sahi M; Kachekouche Y; Benosman C
Biol Trace Elem Res; 2024 Jun; 202(6):2450-2456. PubMed ID: 37725315
[TBL] [Abstract][Full Text] [Related]
6. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress Markers and Metal Ions are Correlated With Cognitive Function in Alzheimer's Disease.
Pu Z; Xu W; Lin Y; He J; Huang M
Am J Alzheimers Dis Other Demen; 2017 Sep; 32(6):353-359. PubMed ID: 28554217
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort.
Pala V; Agnoli C; Cavalleri A; Rinaldi S; Orlandi R; Segrado F; Venturelli E; Vinceti M; Krogh V; Sieri S
Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1209-1215. PubMed ID: 35255128
[TBL] [Abstract][Full Text] [Related]
9. High serum Cu and Cu/Zn ratios correlate with impairments in bone density, physical performance and overall health in a population of elderly men with frailty characteristics.
Gaier ED; Kleppinger A; Ralle M; Mains RE; Kenny AM; Eipper BA
Exp Gerontol; 2012 Jul; 47(7):491-6. PubMed ID: 22484083
[TBL] [Abstract][Full Text] [Related]
10. Mis-regulation of Zn and Mn homeostasis is a key phenotype of Cu stress in Streptococcus pyogenes.
Hong Y; Mackenzie ES; Firth SJ; Bolton JRF; Stewart LJ; Waldron KJ; Djoko KY
Metallomics; 2023 Nov; 15(11):. PubMed ID: 37849243
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer's disease.
Alsadany MA; Shehata HH; Mohamad MI; Mahfouz RG
Am J Alzheimers Dis Other Demen; 2013 Feb; 28(1):54-61. PubMed ID: 23242124
[TBL] [Abstract][Full Text] [Related]
12. Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.
Bagheri S; Squitti R; Haertlé T; Siotto M; Saboury AA
Front Aging Neurosci; 2017; 9():446. PubMed ID: 29472855
[TBL] [Abstract][Full Text] [Related]
13. Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment.
Mueller C; Schrag M; Crofton A; Stolte J; Muckenthaler MU; Magaki S; Kirsch W
J Alzheimers Dis; 2012; 29(2):341-50. PubMed ID: 22232013
[TBL] [Abstract][Full Text] [Related]
14. Zinc unbound concentration as an anchor to drive individualize repletion.
Metsu D; Cinq-Frais C; Camare C; Caspar-Bauguil S; Galinier A
Clin Nutr; 2024 Apr; 43(4):1021-1023. PubMed ID: 38513551
[TBL] [Abstract][Full Text] [Related]
15. Copper: From enigma to therapeutic target for neurological disorder.
Patwa J; Flora SJS
Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):778-791. PubMed ID: 38622813
[TBL] [Abstract][Full Text] [Related]
16. Impact of aging on copper isotopic composition in the murine brain.
Lahoud E; Moynier F; Luu TH; Mahan B; Borgne ML
Metallomics; 2024 May; 16(5):. PubMed ID: 38289854
[TBL] [Abstract][Full Text] [Related]
17. Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors.
Sverdrup Efjestad A; Ihle-Hansen H; Hjellvik V; Blix HS
Dement Geriatr Cogn Dis Extra; 2017; 7(1):30-40. PubMed ID: 28413414
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer's patients.
Al-Hamed FS; Kouniaris S; Tamimi I; Lordkipanidzé M; Madathil SA; Kezouh A; Karp I; Nicolau B; Tamimi F
Alzheimers Dement (N Y); 2021; 7(1):e12184. PubMed ID: 34458554
[TBL] [Abstract][Full Text] [Related]
19. Increased Copper in Individuals with Autism Normalizes Post Zinc Therapy More Efficiently in Individuals with Concurrent GI Disease.
Russo AJ
Nutr Metab Insights; 2011; 4():49-54. PubMed ID: 23946661
[TBL] [Abstract][Full Text] [Related]
20. Agricultural Use of Copper and Its Link to Alzheimer's Disease.
Coelho FC; Squitti R; Ventriglia M; Cerchiaro G; Daher JP; Rocha JG; Rongioletti MCA; Moonen AC
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32545484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
